Latham wins crucial patent suit for biotech client Prometheus

September 18, 2009 Latham & Watkins helped its client Prometheus Laboratories overturn a ruling concerning the patentability of the company's method to treat Crohn's disease and other inflammatory bowel conditions.

The lower court's holding in favor of Mayo Collaborative Services and Mayo Clinic Rochester had raised the fear that many diagnostic and treatment method patents might not be valid.

Read more at amlawdaily.typepad.com.

comments powered by Disqus